Levofloxacin 500 mg Tablets

Product Description

• Broad spectrum Antibacterial activity against Gram Positive, Gram Negative,a typicals and anaerobes.
• In Acute Bacterial Exacerbtion of Chronic Bronchitis (ABECB) 97.1% pathogens are suspectible to levofloxacin while 90.6% are susceptible to amoxi/clav.
• Levofloxacin(250 mg.OD) showed equivalent efficacy compared with ofloxacin (200 mg.BID) in Acute Uncimplicated bacterial Cystitis with lesser side effects.
• Levofloxacin 500 mg OD is as effective as and well tolerated than Cefuroxime Axetil 250 mg b.i.d for 7-10 days in treatment of AECB in adult patients

• One tablet in a day